Skip to main content
. 2014 Feb 12;8(3):269–286. doi: 10.1007/s12105-014-0527-7

Table 6.

Summary of patient outcome (in 19 available patients)

All patients A, NED A, D D, D
All patients with follow-up (mean years) 19 (2.3) 14 (2.6) 4 (1.5) 1 (2.4)
Follow-up range (years) 0.3–6.5 0.3–6.5 0.2–3.3 2.4
Gender
 Females 6 (2.6) 5 (2.9) 1 (1.0) n/a
 Males 13 (2.2) 9 (2.4) 3 (1.6) 1 (2.4)
Age
 <60 years 10 (2.2) 7 (2.5) 3 (1.6) n/a
 ≥60 years 9 (2.4) 7 (2.7) 1 (1.0) 1 (2.4)
Size
 <4.0 cm 10 (2.1) 6 (2.9) 3 (0.8) 1 (2.4)
 ≥4.0 cm 9 (2.5) 8 (2.4) 1 (3.5) n/a
Anatomic site
 Nasal cavity alone 3 (3.1) 2 (4.2) 1 (1.0) n/a
 Single sinus alone (maxillary, ethmoid or sphenoid) 6 (2.0) 4 (2.2) 1 (1.0) 1 (2.4)
 Mixed 10 (2.3) 8 (2.4) 2 (1.9) n/a
 Patients with a recurrence 3 (2.3) n/a 2 (2.5) 1 (2.4)
 Patients without a recurrence 16 (2.4) 14 (2.6) 2 (0.6) n/a
Grade
 1 (Low) 5 (2.1) 4 (2.4) 1 (1.0) n/a
 2 (Intermediate) 5 (1.3) 3 (0.9) 2 (1.9) n/a
 3 (High) 9 (3.1) 7 (3.5) 1 (1.0) 1 (2.4)
Stage
 0 1 (1.0) n/a 1 (1.0) n/a
 I 2 (2.2) 2 (2.2) n/a n/a
 II 3 (1.5) 1 (1.2) 1 (1.0) 1 (2.4)
 III 7 (3.5) 7 (3.5) n/a n/a
 IV 6 (1.7) 4 (1.5) 2 (1.9) n/a

A, NED Alive, no evidence of disease, D, NED Dead, no evidence of disease, D, D Dead with disease